Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
All articles
Showing 85–96 of 411 articles
- Check methods and identity
What a night of sleep measurements adds to an endocrine study
CJC-1295 (No DAC) / GHRP-6 pairs the label commonly used for a synthetic relative of growth hormone–releasing hormone with a six-residue peptide that activates the ghrelin receptor. How can sleep recordings and hormone readings answer different questions about this pathway?
CJC-1295 (No DAC) / GHRP-62 sources (1995, 2024)
- Check methods and identity
What a combination label can establish about the material inside
CJC-1295 (No DAC) / Ipamorelin names a 29-residue modified growth hormone–releasing factor and a separate five-residue agonist of the ghrelin receptor. Which parts of that identity can a catalog label establish?
CJC-1295 (No DAC) / Ipamorelin3 sources (2024, 2026)
- Explore study findings
What was actually paired with ipamorelin in a rat muscle experiment?
CJC-1295 (No DAC) / Ipamorelin combines a name commonly used for Mod GRF (1–29), a modified growth hormone–releasing hormone fragment, with a synthetic five-residue peptide called ipamorelin. Looking at a muscle-force claim starts with identifying which compounds the underlying experiment used.
CJC-1295 (No DAC) / Ipamorelin2 sources (2001, 2024)
- Understand the science
What a single-compound time course can show about a proposed pairing
CJC-1295 (No DAC) / Ipamorelin names a modified growth hormone–releasing hormone fragment and ipamorelin, a five-residue ghrelin-receptor agonist. Would the timing of ipamorelin's effect by itself predict the timing of the two-peptide response?
CJC-1295 (No DAC) / Ipamorelin2 sources (1999, 2024)
- Understand the science
How researchers defined hormone selectivity for ipamorelin
The label CJC-1295 (No DAC) / Ipamorelin refers to modified growth hormone–releasing factor (1–29) alongside a synthetic five-residue growth hormone secretagogue. In the original ipamorelin research, what did it mean to describe the compound as selective?
CJC-1295 (No DAC) / Ipamorelin3 sources (1998, 2024)
- Understand the science
How a bowel-surgery trial differed from a growth hormone experiment
CJC-1295 (No DAC) / Ipamorelin pairs the modified growth hormone–releasing factor known as Mod GRF (1–29) with a five-residue ghrelin-receptor agonist. Why did a clinical trial of ipamorelin focus on when patients could eat after surgery?
CJC-1295 (No DAC) / Ipamorelin3 sources (2014, 2024)
- Explore study findings
What a study would need to attribute a response to either peptide
CJC-1295 (No DAC) / Ipamorelin lists a modified 29-residue growth hormone–releasing hormone analogue and a five-residue agonist of the ghrelin receptor. Would comparing the two together against a control be enough to tell how they interact?
CJC-1295 (No DAC) / Ipamorelin3 sources (1995, 2024)
- Explore study findings
Why Researchers Named DSIP After a Brain Wave
DSIP, short for delta sleep-inducing peptide, is a nine-amino-acid chain also called emideltide. Its name reflects a result in an early animal experiment. Delta refers to slow electrical waves that can be measured with an electroencephalogram, or EEG.
DSIP2 sources (1978, 2026)
- Explore study findings
What a Controlled DSIP Insomnia Study Found
DSIP, or emideltide, is a nine-amino-acid peptide studied in sleep research. The question here is whether it improved chronic insomnia, a condition involving trouble sleeping together with consequences during the day. The 2026 FDA appraisal found that the human evidence remains inconclusive.
DSIP2 sources (1992, 2026)
- Interpret the evidence
What a Small DSIP Study in Healthy Volunteers Can Tell Us
Delta sleep-inducing peptide, called DSIP or emideltide, was tested in an early human study that asked how sleep changed in healthy volunteers. No recent controlled study addressing that same healthy-volunteer question was identified, so the original report is the direct source.
DSIP2 sources (1981, 2026)
- Explore study findings
Why DSIP Behaved Differently During Anesthesia
DSIP, also known as emideltide, attracted attention because of early findings about slow brain waves. A small anesthesia experiment asked whether the same molecule would deepen an already induced state of unconsciousness.
DSIP1 source (2009)
- Interpret the evidence
Why the DSIP Withdrawal Reports Cannot Establish a Treatment Effect
Peptides are short chains of amino acids linked by peptide bonds. Researchers sometimes test whether a chain influences several signals at once, but a change in symptoms can have more than one cause.
DSIP3 sources (1984–2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
